Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2COSENTYX

02 1DARZALEX

03 1GAMIFANT

04 1IMJUDO

05 1ONTRUZANT

06 1OPDUALAG

07 1SYLVANT

08 1VYEPTI

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

ISPE Annual Meeting
Not Confirmed
arrow

02

ISPE Annual Meeting
Not Confirmed
arrow

03

ISPE Annual Meeting
Not Confirmed
arrow

05

ISPE Annual Meeting
Not Confirmed
arrow

06

ISPE Annual Meeting
Not Confirmed
arrow

07

ISPE Annual Meeting
Not Confirmed
arrow

08

ISPE Annual Meeting
Not Confirmed
arrow

09

RECORDATI RARE DISEASES, INC.

Siltuximab

ISPE Annual Meeting
Not Confirmed
arrow
RECORDATI RARE DISEASES, INC.
arrow
ISPE Annual Meeting
Not Confirmed

SILTUXIMAB

Drug : SYLVANT

Dosage Form : INJECTABLE; INJECTION

Application Number : 125496

Country : US

Patented : No

blank